COVERGIRL vs AbbVie

Side-by-side comparison of AI visibility scores, market position, and capabilities

AbbVie leads in AI visibility (90 vs 76)

COVERGIRL

LeaderBeauty & Personal Care

Cosmetics and Make-Up

Coty (NYSE: COTY) mass cosmetics brand with cruelty-free certification and 40+ foundation shades; competing with L'Oréal Paris and Maybelline in drugstore for mass beauty market with clean and inclusive positioning.

AI VisibilityBeta
Overall Score
B76
Category Rank
#1 of 4
AI Consensus
52%
Trend
stable
Per Platform
ChatGPT
68
Perplexity
83
Gemini
74

About

COVERGIRL is Coty Inc.'s (NYSE: COTY) mass-market cosmetics brand — offering foundation, concealer, mascara, lipstick, eyeliner, eyeshadow, blush, and nail polish targeting the drugstore and mass retail beauty consumer at $6-$20 price points. Founded in 1961 as a division of Noxell Corporation and acquired by Coty in 2016 for $12 billion (purchased from Procter & Gamble), COVERGIRL operates in 20+ countries and remains one of the most recognized beauty brands in North America, known for iconic advertising campaigns featuring celebrities from Christie Brinkley (1970s-2000s) to Queen Latifah, Ellen DeGeneres, and more recently diverse influencer brand ambassadors.

Full profile

AbbVie

LeaderHealthcare

General

Global pharma company with $55B 2024 revenue; successfully diversifying beyond Humira with Skyrizi, Rinvoq, and $8.7B Cerevel neuroscience acquisition.

AI VisibilityBeta
Overall Score
A90
Category Rank
#9 of 1167
AI Consensus
60%
Trend
stable
Per Platform
ChatGPT
99
Perplexity
99
Gemini
83

About

AbbVie is a global research-based biopharmaceutical company focused on developing treatments for complex and serious diseases including immunology, oncology, neuroscience, aesthetics, and eye care. Spun off from Abbott Laboratories in 2013 and headquartered in North Chicago, Illinois, AbbVie rapidly became one of the world's top pharmaceutical companies on the strength of Humira — the world's best-selling drug for over a decade with peak annual sales exceeding $20 billion. AbbVie is listed on the NYSE and is a component of the S&P 500 and Dow Jones Industrial Average.

Full profile

AI Visibility Head-to-Head

76
Overall Score
90
#1
Category Rank
#9
52
AI Consensus
60
stable
Trend
stable
68
ChatGPT
99
83
Perplexity
99
74
Gemini
83
84
Claude
96
87
Grok
95

Track AI Visibility in Real Time

Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.